AnaptysBio Announces Presentation at the J.P. Morgan 36th Annual Healthcare Conference
Jan 02, 2018 11:30 am UTC| Business
SAN DIEGO, Jan. 02, 2018 -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation, today announced...
Jan 02, 2018 11:18 am UTC| Business
Dublin, Jan. 02, 2018 -- The "In Vitro Diagnostics: Technologies and Global Markets" report has been added to Research and Markets' offering. The Global in Vitro Diagnostics (IVD) Market Should Reach...
Global $1.9 Billion Cancer Stem Cells Technologies and Markets, 2022
Jan 02, 2018 11:05 am UTC| Business
Dublin, Jan. 02, 2018 -- The "Cancer Stem Cells: Technologies and Global Markets" report has been added to Research and Markets' offering. The Global Market for Cancer Stem Cells Will Grow from $745...
Siyata Mobile Announces All 50 States Opt-In for United States FirstNet Public Safety Network
Jan 02, 2018 11:05 am UTC| Business
MONTRAL, Jan. 02, 2018 -- Siyata Mobile Inc. (the “Company” or “Siyata”) (TSX-V:SIM) (OTCQX:SYATF) is pleased to announce that on December 29, 2017, all 50 states opted-in for the FirstNet “Band 14” Network, a...
Jan 02, 2018 11:00 am UTC| Business
JACKSONVILLE, FL, Jan. 02, 2018 -- mCig, Inc (OTCQB: MCIG), a leading distributor of innovative products, customized packaging solutions, technologies, and services for the global medical cannabis industry, is pleased...
Jan 02, 2018 11:00 am UTC| Business
CAMBRIDGE, Mass. and BEIJING, China, Jan. 02, 2018 -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and...
Radware Schedules Conference Call for Fourth Quarter 2017 Earnings and Hosts Investor Meeting
Jan 02, 2018 11:00 am UTC| Business
TEL AVIV, Israel, Jan. 02, 2018 -- Radware® (NASDAQ:RDWR), a leading provider of cyber security and application delivery solutions, today announced that it has scheduled its earnings call to discuss its fourth quarter...